A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate
Public ClinicalTrials.gov record NCT00298987. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Study of Dasatinib (BMS-354825) in Subjects With Chronic Myelogenous Leukemia With Accelerated or Myeloid or Lymphoid Blast Phase or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Who Are Resistant to or Intolerant of Imatinib Mesylate
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical research study is to provide dasatinib treatment to patients with advanced chronic myelogenous leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) who no longer can tolerate treatment with imatinib. The safety of the treatment will also be studied.
Study identification
- NCT ID
- NCT00298987
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 400 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2006 (Type not available)
- Primary completion
- Jun 2007 (Actual)
- Completion
- Jun 2007 (Actual)
- Last update posted
- Feb 8, 2010
2006 – 2007
United States locations
- U.S. sites
- 30
- U.S. states
- 21
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Corona | California | — | — |
| Local Institution | Aurora | Colorado | — | — |
| Local Institution | Colorado Springs | Colorado | — | — |
| Local Institution | Waterford | Connecticut | — | — |
| Local Institution | Daytona Beach | Florida | — | — |
| Local Institution | Jupiter | Florida | — | — |
| Local Institution | Atlanta | Georgia | — | — |
| Local Institution | Lawrenceville | Georgia | — | — |
| Local Institution | Beach Grove | Indiana | — | — |
| Local Institution | Indianapolis | Indiana | — | — |
| Local Institution | Iowa City | Iowa | — | — |
| Local Institution | Kansas City | Kansas | — | — |
| Local Institution | Salina | Kansas | — | — |
| Local Institution | Lexington | Kentucky | — | — |
| Local Institution | Louisville | Kentucky | — | — |
| Local Institution | Boston | Massachusetts | — | — |
| Local Institution | Ann Arbor | Michigan | — | — |
| Local Institution | Detroit | Michigan | — | — |
| Local Institution | Santa Fe | New Mexico | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | Cincinnati | Ohio | — | — |
| Local Institution | Cleveland | Ohio | — | — |
| Local Institution | Lawton | Oklahoma | — | — |
| Local Institution | Tulsa | Oklahoma | — | — |
| Local Institution | Portland | Oregon | — | — |
| Local Institution | Providence | Rhode Island | — | — |
| Local Institution | Charleston | South Carolina | — | — |
| Local Institution | Chattanooga | Tennessee | — | — |
| Local Institution | Spokane | Washington | — | — |
| Local Institution | Sheboygan | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00298987, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 8, 2010 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00298987 live on ClinicalTrials.gov.